Generic placeholder image

Applied Drug Research, Clinical Trials and Regulatory Affairs

Editor-in-Chief

ISSN (Print): 2667-3371
ISSN (Online): 2667-338X

Review Article

Comparative Study on Law Relating to Orthopedic Implants in India, the United States and European Union with Case Study

Author(s): Lohithasu Duppala* and Kolapalli Venkata Ramana Murthy

Volume 8, Issue 2, 2021

Published on: 27 April, 2021

Article ID: e270421193047 Pages: 13

DOI: 10.2174/2213476X07666210427105549

Price: $65

Abstract

Background: The article provides a brief discussion on the comparative regulations on orthopedic implants in India, the United States, and European Union. Orthopedic implants are type of high-risk medical devices manufactured to substitute or replace a missing or damaged joint or bone or to support a damaged bone or joint and to improve the quality of life of patients. Thus, there is a need to regulate the import, manufacture, clinical investigation, sale, and distribution of orthopedic implants to ensure that all orthopedic implants that were brought to market are safe quality and performance. The orthopedic implants industry is adversely affected by a lack of awareness of proper regulatory practices, lack of awareness of the current regulatory practices, separate consistent standards, separate lawful requirements, and proper guidance on the quality system, etc.

Conclusion: The objective of this article is to harmonize the regulatory requirements at par with the internationally accepted regulations and to develop an ecosystem in the country to boost the Indian orthopedic device sector, and that will make India more productive for orthopedic device development to encourage national and multinational orthopedic implants industries to manufacture their orthopedic implants in India.

Keywords: Orthopedic implants, case study, regulatory practices, India, United States and EU, biological response

Graphical Abstract

[1]
Hip Replacement Recall. 2018. Available from: https://www.drugwatch.com/hip-replacement/recalls/ [Accessed on 19.01.2018].
[2]
The Medical Devices Rules published in the Official Gazette by Government of India vide GSR 2017; 78(E): 155-7.
[3]
Loder RT, Feinberg JR. Orthopaedic implants in children: survey results regarding routine removal by the pediatric and nonpediatric specialists. J Pediatr Orthop 2006; 26(4): 510-9.
[http://dx.doi.org/10.1097/01.bpo.0000214924.02939.62] [PMID: 16791071]
[4]
The Medical Devices Rules published in the Official Gazette by Government of India vide GSR 2017; 78(E): 152-5.
[5]
Implantable Medical Devices: 3 Common Misconceptions published by Precision Concepts Group. 2018. Available from: https://www.precisionconcepts.com/implantable-medical-devices-3- common-misconceptions [Accessed on 16.05.2018].
[6]
European Commission, medical devices: guidance document-Classification of medical devices, MEDDEV 2. 4/1 Rev 92018; Available from: file:///C:/Users/dELL/Downloads/2_4_1_rev_9_classification_en%20(1).pdf [Accessed on 16.05.2018].
[7]
Faulty hip implants: Johnson and Johnson draws up India-specific reimbursement programme 2018. Available from: https://www.livemint.com/Companies/UJuuXzCKGXwTB0fsPg9k2M/Faulty-hip-implants-Johnson-and-Johnson-draws-up-Indiaspec.html [Accessed on 10.12.2018].
[8]
Böstman OM. Metallic or absorbable fracture fixation devices. A cost minimization analysis. Clin Orthop Relat Res 1996; (329): 233-9.
[http://dx.doi.org/10.1097/00003086-199608000-00029] [PMID: 8769457]
[9]
Ramesh A. Johnson and Johnson faulty hip implants, curse to the Indian Patients. Int J Res Analyt Rev 2019; 6(1): 933-7.
[10]
Won’t move panel, say many affected by Johnson and Johnson hip implants 2010. Available from: https://timesofindia.indiatimes.com/city/mumbai/most-payout-claims-for-faulty-jj-hip-implants-erroneous/articleshow/67032180.cms [Accessed on 11.10.2010].
[11]
Faulty hip implants: Johnson & Johnson may have to pay each patient Rs20 lakh. 2017. Available from: https://www.livemint.com/Companies/45x5h9TJGlzfC3QiavoowN/Faulty-hip-implants-Johnson--Johnson-may-have-to-pay-each.html [Accessed on 20.11.2017].
[12]
Patients with faulty Johnson & Johnson hip implants to be compensated up to Rs 1.23 crore. 2018. Available at: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-okays-compensation-formula-for-johnson-johnson- faulty-hip-implant-patients/articleshow/66871010.cms [Accessed on 13.08.2017].
[13]
Patients with faulty Johnson & Johnson hip implants to be compensated up to Rs 1.23 crore. Available at: https://www.thehindubusinessline.com/companies/jjs-move-to-correct-hip-implant-fiasco-inadequate-patients/article25412315.ece [Accessed on 03.11.2018].
[14]
Govt to track patients with faulty J&J hip implant to ensure compensation 2018. Available from: https://www.hindustantimes.com/india-news/govt-to-track-patients-with-faulty-j-j-hip-implant- to-ensure-compensation/story-DgLbqitf3OB5KI3a3aAKjO.html [Accessed on 24.08.2018].
[17]
Hip Replacement Recall. Available from: https://www.drugwatch.com/knee-replacement/recalls/ [Accessed on 28.10.2019].
[18]
Wienroth M, McCormack P, Joyce TJ. Precaution, governance and the failure of medical implants: the ASR((TM)) hip in the UK. Life Sci Soc Policy 2014; 10: 19.
[http://dx.doi.org/10.1186/s40504-014-0019-2] [PMID: 26573983]
[19]
Anne L, Alan JS, Daniel P, Amanda I, Adler B, Andrew JC. The role of national registries in improving patient safety for hip and knee replacements. 2017; 18: 1-7.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy